Monday, September 20, 2021 10:59:23 AM
Quote:
Novartis weighs entry into mRNA technology, chairman tells paper
ZURICH, July 1 (Reuters) - Swiss drugmaker Novartis NOVN.S could get into the field of messenger ribonucleic acid (mRNA) technology, which has come to the fore in vaccine development during the coronavirus pandemic, Chairman Joerg Reinhardt said in a newspaper interview.
In the Aargauer Zeitung interview, Reinhardt also highlighted the company's resurgent interest in anti-infective products that has also been driven by the pandemic.
"The mRNA technology has proven to be an attractive option in this situation and of course every research company is questioning whether they should invest more in this area," he told the Swiss paper.
"Novartis is doing the same and we are having the discussion this week in the executive committee and then in August in the board of directors," he added without being more specific.
Novartis had joined many other companies in 2018 when it abandoned anti-viral and anti-bacterial research at a facility in California, as it concluded the probability of success was relatively low and wanted to re-direct resources to other areas like gene therapy.
"We are now reassessing that," Reinhardt said, as the pandemic has resurrected the company's interest in anti-infectives.
https://www.nasdaq.com/articles/novartis-weighs-entry-into-mrna-technology-chairman-tells-paper-2021-07-01-0
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM